Isofol Medical AB (publ) (STO:ISOFOL)
0.9900
+0.0350 (3.66%)
Nov 20, 2026, 5:29 PM CET
Isofol Medical AB Market Cap
Isofol Medical AB has a market cap or net worth of 317.29 million as of November 20, 2026. It is the 33,084th most valuable company in the world and the 444th biggest in Sweden. Its market cap has increased by 63.23% in one year.
Market Cap
317.29M
Enterprise Value
219.20M
Revenue
n/a
Global Rank
Country Rank
#444 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since April 4, 2017, Isofol Medical AB's market cap has decreased from 853.32M to 317.29M, a decrease of -62.82%. That is a compound annual growth rate of -9.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 317.29M | 54.83% |
| Dec 30, 2025 | 204.93M | -42.85% |
| Dec 30, 2024 | 358.56M | 204.11% |
| Dec 29, 2023 | 117.91M | -1.35% |
| Dec 30, 2022 | 119.52M | -91.99% |
| Dec 30, 2021 | 1.49B | -36.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 4, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xspray Pharma AB | 496.93M |
| FluoGuide | 482.30M |
| Sprint Bioscience AB | 400.96M |
| Corline Biomedical AB | 375.01M |
| Cantargia AB | 360.89M |
| Intervacc AB | 231.07M |
| Xbrane Biopharma AB | 219.45M |
| Mendus AB | 212.94M |